NeuroPace, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
NPCE Nasdaq 3841 www.neuropace.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for NeuroPace, Inc.

Why Is NeuroPace (NPCE) Down 0.4% Since Last Earnings Report? - Sep 10th, 2026 9:30 am
Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now - Sep 4th, 2026 7:58 am
NeuroPace to Participate in 2026 Cantor Global Healthcare Conference - Sep 1st, 2026 3:01 pm
NeuroPace to Participate in Wells Fargo 21st Annual Healthcare Conference - Aug 31st, 2026 2:05 pm
NeuroPace Inc (NPCE) (Q2 2026) Earnings Call Highlights: Strong RNS Growth and AI Launch Offset ... - Aug 18th, 2026 7:01 pm
NeuroPace Faces an IGE Delay: What the FDA Setback Means for Growth - Aug 17th, 2026 11:17 am
Is NeuroPace a Buy as Growth Improves but Valuation Stays Elevated? - Aug 17th, 2026 11:06 am
NPCE Is Down 12.7% in 3 Months: Is the Pullback a Buying Opportunity? - Aug 17th, 2026 10:59 am
NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up - Aug 12th, 2026 9:22 am
NeuroPace, Inc. Q2 2026 Earnings Call Summary - Aug 12th, 2026 6:30 am
NeuroPace Q2 Earnings Call Highlights - Aug 11th, 2026 6:04 pm
NeuroPace, Inc. (NPCE) Reports Q2 Loss, Tops Revenue Estimates - Aug 11th, 2026 3:25 pm
NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance - Aug 11th, 2026 2:05 pm
NeuroPace FDA Bid for Expanded Epilepsy Use Stalls as Agency Seeks More Data - Jul 28th, 2026 4:04 pm
NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy - Jul 28th, 2026 2:01 pm
Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now - Jul 15th, 2026 8:23 am
NeuroPace, Inc. (NPCE) Reveals FDA Approval of ECoG Assistant™ - Jun 27th, 2026 9:31 am
NeuroPace (NPCE) Down 0.6% Since Last Earnings Report: Can It Rebound? - Jun 11th, 2026 9:30 am
Here's Why You Should Add NeuroPace Stock to Your Portfolio Now - Jun 10th, 2026 8:38 am